The Cleveland Clinic Health System has won an award from the Joint Commission on Accreditation of Healthcare Organizations for its stroke quality improvement program.
The Cleveland-based organization won JCAHO's Ernest A. Codman award, which recognizes excellence in the use of outcomes measurement, the Oakbrook Terrace, Ill.-based accreditor says in a release.
The Cleveland Clinic's stroke quality improvement program approximately doubled the rate of use of intravenous tissue plasminogen activator (IV tPA), the only FDA-approved therapy for acute stroke, and reduced the frequency of brain hemorrhagic complications by more than half, the clinic says in its own release.
Although IV tPA can reduce disability in some stroke patients, it also cause bleeding if not administered carefully, the clinic says. The key to success of the initiative, it says, was the systemwide multidisciplinary involvement among emergency medicine physicians, neurologists, neurosurgeons, neuroradiologists, internists, quality improvement coordinators and emergency medical service personnel.
The clinic says the initiative also enhanced care for all stroke patients through use of standardized guidelines and algorithms; improved professional education and public awareness; reduced stroke complications, mortality and length of stay; and refined processes for measuring stroke outcomes and quality of care.